Synchrony Bio

Synchrony Bio is a venture capital firm established in 2018 and located in Saint Louis, Missouri. It focuses on early-stage investments in the biomedical, medical device, and life science sectors. The firm aims to mitigate risk while enhancing value and efficiency in the development of its portfolio companies. By concentrating on innovative ventures, Synchrony Bio seeks to contribute to advancements in healthcare and technology.

Charles Bolten

Co-Founder and Managing Director

James Merselis

Co-Founder and Managing Director

Alan Rathjen

Principal

1 past transactions

Journeys Metabolic

Seed Round in 2019
Journeys Metabolic is a digital solution provider focused on metabolic care, specifically addressing obesity and Type 2 diabetes. The company offers a six-month, in-home program that integrates advanced technology, including AI-driven precision pathways and computer vision for food education, to facilitate sustained behavior modification. This HITRUST-compliant platform is designed to help health systems transition to value-based care without adding to the burden on care teams. By targeting insulin resistance and related chronic conditions, Journeys Metabolic supports shared savings optimization in metabolic diseases and nutrition-related disorders through tailored nutritional interventions. The program aims to improve patient outcomes by extending primary care into the home and fostering a fee-for-outcomes model in healthcare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.